Kumar; V. Satish
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kumar; V. Satish.The latest application filed is for "human plasma kallikrein inhibitors".
Company Profile
13.20.31
Trademarks
- Kumar; V. Satish - Birmingham AL
- Kumar; V. Satish - Durham NC
Trademarks
Patent Activity
| Patent | Date |
|---|---|
| Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors Grant 11,370,774 - Kotian , et al. June 28, 2 | 2022-06-28 |
| Human Plasma Kallikrein Inhibitors App 20220098151 - Kotian; Pravin L. ; et al. | 2022-03-31 |
| Human plasma kallikrein inhibitors Grant 11,230,530 - Kotian , et al. January 25, 2 | 2022-01-25 |
| Human plasma kallikrein inhibitors Grant 11,203,574 - Kotian , et al. December 21, 2 | 2021-12-21 |
| Human plasma kallikrein inhibitors Grant 11,192,861 - Kotian , et al. December 7, 2 | 2021-12-07 |
| Substituted Benzofuran, Benzopyrrole, Benzothiophene, And Structurally Related Complement Inhibitors App 20210221786 - Kotian; Pravin L. ; et al. | 2021-07-22 |
| Human plasma kallikrein inhibitors Grant 11,066,360 - Kotian , et al. July 20, 2 | 2021-07-20 |
| Prodrugs Of Kallikrein Inhibitors App 20210198204 - Kotian; Pravin L. ; et al. | 2021-07-01 |
| Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors Grant 11,021,458 - Kotian , et al. June 1, 2 | 2021-06-01 |
| Human Plasma Kallikrein Inhibitors App 20210078952 - Kotian; Pravin L. ; et al. | 2021-03-18 |
| Human Plasma Kallikrein Inhibitors App 20210047276 - Kotian; Pravin L. ; et al. | 2021-02-18 |
| Human Plasma Kallikrein Inhibitors App 20210047275 - Kotian; Pravin L. ; et al. | 2021-02-18 |
| Human Plasma Kallikrein Inhibitors App 20200361867 - Kotian; Pravin L. ; et al. | 2020-11-19 |
| Prodrugs of kallikrein inhibitors Grant 10,759,759 - Kotian , et al. Sep | 2020-09-01 |
| Human plasma kallikrein inhibitors Grant 10,689,346 - Kotian , et al. | 2020-06-23 |
| Human plasma kallikrein inhibitors Grant 10,633,345 - Kotian , et al. | 2020-04-28 |
| Human plasma kallikrein inhibitors Grant 10,562,850 - Kotian , et al. Feb | 2020-02-18 |
| Prodrugs Of Kallikrein Inhibitors App 20190382344 - Kotian; Pravin L. ; et al. | 2019-12-19 |
| Substituted Benzofuran, Benzopyrrole, Benzothiophene, And Structurally Related Complement Inhibitors App 20190345135 - Kotian; Pravin L. ; et al. | 2019-11-14 |
| Human Plasma Kallikrein Inhibitors App 20190322626 - Kotian; Pravin L. ; et al. | 2019-10-24 |
| Human plasma kallikrein inhibitors Grant 10,329,260 - Kotian , et al. | 2019-06-25 |
| Human Plasma Kallikrein Inhibitors App 20180362458 - Kotian; Pravin L. ; et al. | 2018-12-20 |
| Human Plasma Kallikrein Inhibitors App 20180354906 - Kotian; Pravin L. ; et al. | 2018-12-13 |
| Human plasma kallikrein inhibitors Grant 10,125,102 - Kotian , et al. November 13, 2 | 2018-11-13 |
| Human Plasma Kallikrein Inhibitors App 20180258049 - Kotian; Pravin L. ; et al. | 2018-09-13 |
| Human Plasma Kallikrein Inhibitors App 20170073314 - Kotian; Pravin L. ; et al. | 2017-03-16 |
| Antiviral Azasugar-containing Nucleosides App 20150291596 - Babu; Yarlagadda S. ; et al. | 2015-10-15 |
| Antiviral nucleoside analogs Grant 8,440,813 - Babu , et al. May 14, 2 | 2013-05-14 |
| Hepatitis C Therapies App 20130078218 - Babu; Yarlagadda S. ; et al. | 2013-03-28 |
| Methods for the preparation of 9-deazapurine derivatives Grant 8,344,132 - Chand , et al. January 1, 2 | 2013-01-01 |
| Therapeutic Furopyrimidines And Thienopyrimidines App 20120213735 - Babu; Yarlagadda S. ; et al. | 2012-08-23 |
| Pyrrolo [1,2-b] Pyridazine Derivatives as Janus Kinase Inhibitors App 20120149691 - Babu; Yarlagadda S. ; et al. | 2012-06-14 |
| Heterocyclic Compounds as Janus Kinase Inhibitors App 20120149662 - Babu; Yarlagadda S. ; et al. | 2012-06-14 |
| Antiviral Therapeutic Agents App 20120142617 - Babu; Yarlagadda S. ; et al. | 2012-06-07 |
| Hepatitis C therapies Grant 8,163,703 - Babu , et al. April 24, 2 | 2012-04-24 |
| Therapeutic furopyrimidines and thienopyrimidines Grant 8,133,870 - Babu , et al. March 13, 2 | 2012-03-13 |
| Antiviral therapeutic agents Grant 7,994,139 - Babu , et al. August 9, 2 | 2011-08-09 |
| Piperidine Derivatives As Jak3 Inhibitors App 20110165183 - Babu; Yarlagadda S. ; et al. | 2011-07-07 |
| Synthetic Intermediates And Processes App 20110144321 - Chand; Pooran ; et al. | 2011-06-16 |
| Hepatitis C Therapies App 20100143300 - Babu; Yarlagadda S. ; et al. | 2010-06-10 |
| Methods For The Preparation Of 9-deazapurine Derivatives App 20100093991 - Chand; Pooran ; et al. | 2010-04-15 |
| Antiviral Nucleoside Analogs App 20100015094 - Babu; Yarlagadda S. ; et al. | 2010-01-21 |
| Antiviral Therapeutic Agents App 20090227524 - Babu; Yarlagadda S. ; et al. | 2009-09-10 |
| AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases Grant 7,560,434 - Babu , et al. July 14, 2 | 2009-07-14 |
| Hepatitis C therapies Grant 7,514,410 - Babu , et al. April 7, 2 | 2009-04-07 |
| Therapeutic Furopyrimidines and Thienopyrimidines App 20080300200 - Babu; Yarlagadda S. ; et al. | 2008-12-04 |
| AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases App 20070099942 - Babu; Yarlagadda S. ; et al. | 2007-05-03 |
| Hepatitis C therapies App 20060234963 - Babu; Yarlagadda S. ; et al. | 2006-10-19 |
| Therapeutic furopyrimidines and thienopyrimidines App 20060165655 - Babu; Yarlagadda S. ; et al. | 2006-07-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 